Restoring our ubiquitination machinery to overcome resistance in cancer therapy
- PMID: 38711948
- PMCID: PMC11073315
- DOI: 10.18632/oncoscience.600
Restoring our ubiquitination machinery to overcome resistance in cancer therapy
Keywords: PROTAC; UBE2J1; androgen receptor; antiandrogen resistance; prostate cancer; protein degradation; ubiquitination.
Conflict of interest statement
CONFLICTS OF INTEREST P.M. served as a scientific consultant to Accutar Biotechnology, Inc. Authors have no conflicts of interest to declare.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
